Kool-Aid

Envoy Medical Reports Fourth Quarter and Full Year 2023 Financial Results

Retrieved on: 
Tuesday, April 2, 2024
House, Growth, Congress, Patient, COCH, EFS, Classification, Hope, Esteem, Business analyst, Insurance, Kool-Aid, Clinical trial, Patent, Medicare, Marketing, CMS, Hearing, Representative

WHITE BEAR LAKE, Minn., April 02, 2024 (GLOBE NEWSWIRE) -- Envoy Medical®, Inc. (“Envoy Medical”) (Nasdaq: COCH), a revolutionary hearing health company focused on fully implanted hearing devices, today announced its corporate and financial results for the fourth quarter and full year ended December 31, 2023.

Key Points: 
  • Completed Business Combination transaction at the end of September and began trading on Nasdaq under its own ticker, COCH, the first week of October 2023.
  • Early Feasibility Study (EFS) continues to meet milestones with all three implanted patients surpassing twelve-month post-activation visits remaining implanted.
  • Sales and marketing expenses increased $0.8 million for the year ended December 31, 2023 compared to the same period in 2022.
  • The increase is primarily due to a $2.8 million rise in professional and legal fees in 2023 related to the finalization of the Business Combination in the third quarter of 2023.

Sam's Club Discount Membership (2024) Review Published by Compare Before Buying

Retrieved on: 
Monday, April 1, 2024
Supermarket, Retail, Online Retail, Food, Beverage, Health, EV, Smartphone, Sam's Club, Prescription, Scan, Walmart, Club, Kool-Aid, Sam

Compare Before Buying has recently completed an in-depth analysis of Sam's Club , emphasizing a notable 50% discount on Club memberships for new members.

Key Points: 
  • Compare Before Buying has recently completed an in-depth analysis of Sam's Club , emphasizing a notable 50% discount on Club memberships for new members.
  • This half-price offer unlocks all the standard Club membership benefits, encompassing the extensive savings and exclusive services detailed in the Compare Before Buying review.
  • In addition to the standard Club membership, Sam's Club provides an enhanced tier of membership known as Sam's Club Plus.
  • For individuals interested in exploring the value of a Sam's Club discount membership , the Compare Before Buying review offers a thorough and objective analysis, underlining the significant savings and conveniences that membership can provide, especially at the introductory discounted rate.

Chosgo K23: One of the Best Bluetooth Hearing Aids for Seniors

Retrieved on: 
Friday, March 29, 2024
Huber loss, DSP, Hearing aid, IPhone, Risk, Policy, Sale, Quality of life, TWS, Kool-Aid, Hearing loss, OTC, CIC, Music, Mobile, Multimedia, FDA, Hearing, Android, Deficit spending, Bluetooth

ALBANY, N.Y., March 29, 2024 /PRNewswire-PRWeb/ -- The progressive decrease in hearing in elderly people can represent a major problem for their quality of life: it has in fact been demonstrated that critical issues such as these, in addition to being a problem as such, can favor the onset of cognitive deficits of various types. People affected by hearing loss, therefore with hearing problems, have a risk twice as high as others of developing dementia.

Key Points: 
  • Hearing aids for seniors are almost a necessity and when it comes time to choose, OTC hearing aids like the Chosgo K23 offer even more advantages.
  • However, an FDA policy last October allowing the sale of OTC hearing aids without a prescription has resulted in massive price drops and less oversight of the OTC hearing aids flooding the market.
  • As a result, we recommend one product that we think is one of the best OTC hearing aids .
  • Hearing aids for seniors are almost a necessity and when it comes time to choose, OTC hearing aids like the Chosgo K23 offer even more advantages.

Sony Group Exhibits at the World's Largest International Conference on Accessibility "CSUN Assistive Technology Conference 2024"

Retrieved on: 
Monday, March 18, 2024
Friends, PS5, Ear canal, Braille, Sony Interactive Entertainment, Hearing aid, System, Creativity, Disability, Visual impairment, Television, SAN, Purpose, PlayStation Store, PS4, FX3, PlayStation, Access, PlayStation Studios, IOS, Braille Institute of America, WS Audiology, Organization, Home, Sony, BRAVIA, Senior, Ear, App Store (iOS/iPadOS), OTC, Orientation, Lighthouse, FDA, SONY, Smartphone, Conference, Environment, Name, Light, Imaging, Motion, Home entertainment, Audiology, Google Play, Kool-Aid, Retina, Google TalkBack, Music, Huber loss, Multimedia, Hearing, Video game

SAN DIEGO, March 18, 2024 /PRNewswire/ -- Sony Group ("Sony") announced today that it will have an exhibit at the world's largest international conference on accessibility, the "CSUN Assistive Technology Conference 2024" March 18 to 22 in Anaheim, California.

Key Points: 
  • SAN DIEGO, March 18, 2024 /PRNewswire/ -- Sony Group ("Sony") announced today that it will have an exhibit at the world's largest international conference on accessibility, the "CSUN Assistive Technology Conference 2024" March 18 to 22 in Anaheim, California.
  • Developed in collaboration with the accessibility community, the Access controller features an expansive array of hardware and software customization options.
  • In addition to the above exhibits, Sony will hold Conference Sessions to showcase a selection of accessibility initiatives.
  • Shiro Kambe, Senior Executive Vice President, Sony Group Corporation, and Neal Manowitz, President and COO of Sony Electronics North America, will share video messages regarding accessibility at Sony.

Rexton Launches Rexton Reach Hearing Aid Platform to Ensure Every Voice in Every Conversation is Heard

Retrieved on: 
Tuesday, March 12, 2024
Smartphone, Communication, Environment, ASHA, MFI, Life, Marketing, Kool-Aid, Restaurant, RIC, WS Audiology, Hearing, Human

ISELIN, N.J., March 12, 2024 /PRNewswire/ -- Continuing its legacy of developing solutions that are simple to wear and easy to fit, hearing aid manufacturer Rexton today unveiled Rexton Reach, an all-new hearing aid platform that allows wearers to truly participate in group conversations and hear multiple voices at the same time, even in background noise.

Key Points: 
  • The first hearing aid model built on the Rexton Reach platform is Rexton Reach R-Li T, a rechargeable receiver-in-canal (RIC) hearing aid that ensures every voice within a conversation is clear and recognizable.
  • To be truly engaged in a conversation, hearing aid wearers need to be able to hear each participant clearly and consistently amidst background noise.
  • The Rexton Reach platform also features rechargeability and seamless connectivity for ease of use, while maintaining the proven performance and durability Rexton hearing aids are known for.
  • Rexton Reach R-Li T offers wearers peace of mind that their rechargeable hearing aid will get them through the day.

Sleep Specialist and Otolaryngologist, Julie Zweig, M.D., is Featured as a 2024 Top Patient Rated Doctor by Find Local Doctors

Retrieved on: 
Monday, March 11, 2024
Sleep, Sleep apnea, Hormone, Patient, Insomnia, Sleep medicine, University, MD, Ear, Suite, ENT, Patient satisfaction, Nasal congestion, Hearing loss, Kool-Aid, Medicine, Nose, Allergy, Multimedia, Physician, Hearing, Pharmaceutical industry

ALPHARETTA, Ga., March 11, 2024 /PRNewswire-PRWeb/ -- Dr. Julie Zweig, a renowned, board-certified ear nose and throat (ENT) and sleep medicine physician, has been recognized as a 2024 Top Patient Rated Otolaryngologist by Find Local Doctors. This prestigious title is awarded to practices that have received an exceptional number of five-star ratings and superior reviews from satisfied patients. Find Local Doctors, a trusted online directory, is dedicated to helping consumers find reputable physicians in their area. The recognition bestowed upon Dr. Zweig and her team is a testament to their commitment to providing top-notch care and achieving outstanding patient satisfaction.

Key Points: 
  • ALPHARETTA, Ga., March 11, 2024 /PRNewswire-PRWeb/ -- Dr. Julie Zweig, a renowned, board-certified ear nose and throat (ENT) and sleep medicine physician, has been recognized as a 2024 Top Patient Rated Otolaryngologist by Find Local Doctors.
  • Find Local Doctors , a trusted online directory, is dedicated to helping consumers find reputable physicians in their area.
  • Julie Zweig, MD Integrative Sleep & ENT is located at 2650 Holcomb Bridge Road, Suite 510 in Alpharetta, Georgia.
  • Dr. Julie Zweig, Julie Zweig, MD Integrative Sleep & ENT, 404-255-4080, [email protected] , https://juliezweigmd.com/
    View original content to download multimedia: https://www.prweb.com/releases/sleep-specialist-and-otolaryngologist-jul...

EQS-News: Preliminary financials for FY2023: Fielmann Group grows sales +12%, EBITDA +21%, EBITDA margin +1 percentage point

Retrieved on: 
Wednesday, March 13, 2024
SVS, Acquisition, Hearing, Supervisory board, Annual report, Investment, Marketing, Supervision, VAT, Growth, Vision 2025, Kool-Aid, Cost leadership, EBT, Annual, Retail

In the optical and acoustic industry, this is the Fielmann Group.

Key Points: 
  • In the optical and acoustic industry, this is the Fielmann Group.
  • The German family business significantly extended its market shares across major markets, outperformed its Vision 2025 sales goal, and expanded its EBITDA margin.
  • In 2023 the Fielmann Group generated external sales of around €2.27 billion (incl.
  • In Spain, the Fielmann Group generated +42% sales growth over last year and is therefore progressing swiftly on its course to reach market leadership.

Signia Expands Integrated Xperience (IX) Platform Portfolio with Addition of Discreet, Design-Forward Styletto IX and Insio IX Hearing Aids that Directly Challenge Hearing Aid Stigma

Retrieved on: 
Monday, March 11, 2024
Hearing, IIC, Slim, Noise, SNR, Frustration, Hearing loss, Human, Kool-Aid, Silk, Patient, Huber loss, Speech, CIC, Video game

TORONTO, March 11, 2024 (GLOBE NEWSWIRE) -- Building on the market response to its groundbreaking Integrated Xperience (IX) hearing aid platform, hearing aid innovator Signia is expanding its platform offerings to include Styletto IX, the world’s slimmest & most advanced Slim-RIC hearing aid, and Insio IX, Signia’s smallest and most discreet CIC and IIC hearing aids to date.

Key Points: 
  • TORONTO, March 11, 2024 (GLOBE NEWSWIRE) -- Building on the market response to its groundbreaking Integrated Xperience (IX) hearing aid platform, hearing aid innovator Signia is expanding its platform offerings to include Styletto IX, the world’s slimmest & most advanced Slim-RIC hearing aid, and Insio IX, Signia’s smallest and most discreet CIC and IIC hearing aids to date.
  • The new form factors join Pure Charge&Go IX and Silk Charge&Go IX on the Integrated Xperience platform to unleash the power of conversation while addressing the stigma long associated with wearing hearing aids.
  • “The Signia Integrated Xperience platform is at the forefront of providing unparalleled speech understanding in more challenging listening situations and permitting hearing aid users to be fully engaged in all conversations,” VP of Sales and Practice Development Andre Marcoux said today.
  • Signia Integrated Xperience hearing aids are designed for real conversations in the real world.”
    For more information about the Integrated Xperience platform and currently available hearing aid models, click here .

GN launches The New Norm – a stigma-busting image bank that challenges misperceptions about hearing loss and hearing aids

Retrieved on: 
Sunday, March 3, 2024
Bias, Collection, Hearing, Deafness, Work, Culture, Empowerment, Life, World Hearing Day, Perception, Ear, Hearing loss, Kool-Aid, World Health Organization, Visual perception, Athlete, WHO, Ageing, Communication, Environment, Beauty

BALLERUP, Denmark, March 03, 2024 (GLOBE NEWSWIRE) -- Today GN launches The New Norm, a campaign aiming to tackle the visual misperception people have of modern hearing aids, which contributes to the high level of untreated hearing loss.

Key Points: 
  • On World Hearing Day, GN is launching a stigma-busting photography campaign showcasing real people with hearing loss – from world-class athletes to award-winning musicians – wearing their modern-day hearing aids.
  • BALLERUP, Denmark, March 03, 2024 (GLOBE NEWSWIRE) -- Today GN launches The New Norm, a campaign aiming to tackle the visual misperception people have of modern hearing aids, which contributes to the high level of untreated hearing loss.
  • In response, GN, a global leader in hearing technology, worked with photographer Gala Ricote (who has worn hearing aids for over 20 years) to photograph six inspiring hearing aid wearers.
  • The New Norm image bank provides access to free, high-quality images that represent the modern era of hearing aids and celebrates life with hearing loss.

Fennec Pharmaceuticals Reports Preliminary Unaudited Net Revenue for Fourth Quarter and Full-Year 2023 Results

Retrieved on: 
Thursday, February 29, 2024
Incidence, Osteosarcoma, Fennec, FDA, TSX, Food, Neuroblastoma, Germ cell tumor, Hepatoblastoma, Risk, Literacy, Safety, Audit, Cisplatin, Hearing loss, Medulloblastoma, Kool-Aid, Ototoxicity, Food and Drug Administration, Patient, Survival, FENC, COG

RESEARCH TRIANGLE PARK, N.C., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced preliminary unaudited fourth quarter and full-year 2023 net revenues.

Key Points: 
  • ~ Company Expects to Report 2023 Fourth Quarter and Audited Full-Year Results on or about March 26, 2024 ~
    RESEARCH TRIANGLE PARK, N.C., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced preliminary unaudited fourth quarter and full-year 2023 net revenues.
  • The information in this press release is based upon preliminary unaudited information and management estimates for the fourth quarter 2023 and is subject to the completion of Fennec’s financial closing procedures and year end audit.
  • Preliminary Unaudited 2023 Fourth Quarter Revenue and Year End Performance:
    Fourth quarter 2023 net revenues are expected to be approximately $9.2 to $9.7 million, which represents approximately a 41-49% increase over the third quarter of 2023.
  • Fennec expects to report its 2023 fourth quarter and audited full-year year results of operations on or about March 26, 2024.